Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06505369
Title Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients (TALTEC)
Acronym TALTEC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors North Estonia Medical Centre
Indications
Therapies
Age Groups: senior | adult
Covered Countries NOR | EST | DNK

Facility Status City State Zip Country Details
Copenhagen University Hospital (Rigshospitalet) NOT_YET_RECRUITING Copenhagen 2100 Denmark Details
Odense University Hospital NOT_YET_RECRUITING Odense 5000 Denmark Details
Vejle hospital NOT_YET_RECRUITING Vejle 7100 Denmark Details
North Estonia Medical Centre RECRUITING Tallinn 13419 Estonia Details
Oslo University Hospital, Oslo Myeloma Centre NOT_YET_RECRUITING Oslo 0450 Norway Details
Stavanger University Hospital NOT_YET_RECRUITING Stavanger 4068 Norway Details
St. Olavs Hospital NOT_YET_RECRUITING Trondheim 7030 Norway Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field